Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer (Q50501253)
scientific article published in April 1999
Language:
Current Data About Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer
(P31) (Q13442814)
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P304) 763-770
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P407) (Q1860)

(P433) 8
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P478) 23
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P577) Thursday, April 1, 1999
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P921) (Q172341)
(P887)

(Q974135)
(P887)

(Q423762)
(P887)

(Q415588)
(P887)

(P1433) (Q4941523)
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P1476) "Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer" (language: en)
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

(P2093) Wandt H
(P1545) 1
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Birkmann J
(P1545) 2
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Denzel T
(P1545) 3
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Schäfer K
(P1545) 4
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Schwab G
(P1545) 5
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Pilz D
(P1545) 6
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Egger H
(P1545) 7
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Both A
(P1545) 8
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

Gallmeier WM
(P1545) 9
(P248)
(P698) 10231137
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10231137

other details
description scientific article published in April 1999

External Links
(P356) 10.1038/SJ.BMT.1701659
(P698) 10231137
(P5875) 13067717